What's Happening?
SMi Systems has announced a non-exclusive collaboration with Luminex Corporation to evaluate the integration of Luminex beads with SMi's single-molecule imaging platform. This collaboration aims to assess the feasibility and analytical sensitivity of SMi's technology
compared to Luminex's xMAP readers. SMi's platform allows for the development of multiplexed assays, providing accurate detection of substances in a single test. The collaboration focuses on research activities to validate the potential for SMi's technology to complement Luminex's industry-leading xMAP technology.
Why It's Important?
The collaboration between SMi Systems and Luminex represents a significant step in advancing single-molecule imaging technology. By combining the strengths of both companies, this partnership could lead to more accurate and efficient diagnostic tools. The ability to develop multiplexed assays with high sensitivity and throughput is crucial for biomedical research and diagnostics. This collaboration could enhance the capabilities of laboratories by providing more reliable data, ultimately benefiting research and clinical applications. The integration of these technologies may lead to new innovations in diagnostics and personalized medicine.
